FTSE Developed ex Japan (AD05)

Helen said that she expects Janssen to sign a new contract with halozyme for Faspro and so there might not be any step down in Faspro royalties well into 2030’s.
The rest of Enhanze partner contracts don’t have a step down for as long as there are co-formulation patents (which they all have g

Yeah this one’s headed back to no bid I think unfortunately. You know what they say about it seeming too good to be true.

First Advantage Set to Join S&P SmallCap 600June 11, 2026 6:41 PM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 11, 2026 /PRNewswire/ -- First Advantage Corporation (NASD: FA) will replace Kennedy-Wilson H

Still wondering where controlledoilandgas is? He hasn't posted since cohen went to jail. Must be a coincidence? 🤣🤣🤣

First Advantage Set to Join S&P SmallCap 600June 11, 2026 6:41 PM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 11, 2026 /PRNewswire/ -- First Advantage Corporation (NASD: FA) will replace Kennedy-Wilson H

First Advantage Set to Join S&P SmallCap 600June 11, 2026 6:41 PM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 11, 2026 /PRNewswire/ -- First Advantage Corporation (NASD: FA) will replace Kennedy-Wilson H

Why would they do that ? Sorry but you’re clutching at straws .

We're still on for July 21st, ya? 

Well started. I’m also down 10% really need Ares to produce this month or early July as committed in Feb timeline. 

The IGV today didn't tell the story in software stocks today. why you ask? My screen was fill with software names on the top of the loser list of my watch list. Heck INTU was actually way down the list on that front. The cybersecurity names is what made it look kind of flat, but anything that wasn't

$ECGI! You Are An Idiot 🤣 https://www.youtube.com/watch?v=RQW9dde2JA8

Again trump play the market.
He should investigation by FCC

https://www.barchart.com/stocks/quotes/BCDS/opinion

Posted on behalf of Black Swan Graphene Inc. - Graphene's Industrial Breakout: Black Swan Scales to 140+ Tonnes/Year – The Early-Stage Advanced Materials Play Poised for Explosive Growth

(TSXV: SWAN | OTCQB: BSWGF) has completed a major manufacturing upgrade at its Consett, U.K. faci

According to my Schwab account:
20-Day Moving Average $5.52
50-Day Moving Average $5.57
200-Day Moving Average $6.01

Coinbase Partners with MassPay to Unlock Cross-Border Stablecoin Payouts for Global Enterprises
By Coinbase
Jun 11, 2026

TL;DR: MassPay is integrating Coinbase's payments infrastructure to make cross-border stablecoin payouts faster, cheaper, and more accessible for ente

I understood that the IPO was for $135 are share. 18 shares is all that I could afford.

Is that correct?

Thank You for info. I hope the tides have turned here…. Question - if that’s OK. If halo wins a settlement, 1. They really need to get mid single digits because they won’t be able to offset as product sales like they’ll do with J & J. And 2 - when do think mdase patent will expire? I’m really

That’s two of you now jumping to late autumn today. I think the MimiVax control arm has been under surveillance for quite some time, and likely legally available raw data to NWBO by August 2025, with follow up continuing through now. But I’ll not get in the way of a theme party for late Autumn. I

If you want to try to wrap your head around what's happening here with $MONI use AI to help you.

Take IndexR's most recent update from their website posted on May 19th: https://indexr.ai/616-2/

Then take Google's most recent update about Google's I/O 2026 meeting from

Doc,

>>Fortunately, the tumor was superficial, and it was in the tumor resection cavity from the first surgery. So, the best-case scenario for recurrence.

>> Two days later, I walked out of the hospital. Then I started radiation.

My doctors at UCSF sugges

The Director’s Own Precedent Now Cuts in Halozyme’s Favor:

What happened on May 15, 2026:Director Squires personally denied institution of PGR2025-00087 — the 15th PGR — on RPI grounds. He found the same MCI/MSD RPI issue present, and denied institution without reaching the merits. Sa